ARTICLE SUMMARY:
AVS’ intravascular lithotripsy technology gives Stryker another peripheral vascular technology to complement the Inari venous thromboembolism business it acquired in 2025.
Stryker is building a cardiovascular business with the acquisition of complementary peripheral vascular technologies.
